Mettler-Toledo International Inc. (NYSE:MTD) Holdings Decreased by Bank of Montreal Can

Bank of Montreal Can reduced its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 33.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,078 shares of the medical instruments supplier’s stock after selling 14,769 shares during the quarter. Bank of Montreal Can’s holdings in Mettler-Toledo International were worth $43,004,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of MTD. Family Firm Inc. bought a new stake in shares of Mettler-Toledo International during the second quarter valued at about $25,000. Blue Trust Inc. raised its position in Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in Mettler-Toledo International in the third quarter worth about $37,000. Rothschild Investment LLC bought a new stake in Mettler-Toledo International in the second quarter worth about $42,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Mettler-Toledo International in the second quarter worth about $42,000. 95.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

MTD has been the topic of several research reports. Evercore ISI boosted their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company dropped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $1,338.75.

Insider Activity

In other news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Trading Up 0.9 %

NYSE MTD opened at $1,243.40 on Friday. The stock’s 50-day moving average price is $1,348.27 and its two-hundred day moving average price is $1,395.43. The company has a market cap of $26.24 billion, a PE ratio of 33.52, a PEG ratio of 4.04 and a beta of 1.16. Mettler-Toledo International Inc. has a 1 year low of $1,059.08 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Research analysts forecast that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.